Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  ANTA PHAR       

 SummaryNewsCalendarCompanyFinancialsConsensusRevisions 
Financials ($)
Sales 2015 -
EBIT 2015 -35,3 M
Net income 2015 -36,3 M
Debt 2015 -
Yield 2015 -
Sales 2016 5,00 M
EBIT 2016 -46,2 M
Net income 2016 -41,2 M
Debt 2016 -
Yield 2016 -
PER 2015 -
PER 2016
Capi. / Sales 2015 0
Capi. / Sales 2016 25,9x
Capitalization 129 M
More Financials
Company
Anthera Pharmaceuticals, Inc. is a biopharmaceutical company, which is focused on developing and commercializing products to treat autoimmune diseases.The company's primary product candidate, blisibimod, targets elevated levels of B-cell activating factor, or BAFF, which has been associated with a... 
Sector
Pharmaceuticals
Calendar
05/12Earnings Release
More about the company
Latest news on ANTA PHAR
03/28 ANTHERA PHARMACEUTICALS : Reports Proposed Public Offering of Common Stock
03/25 ANTHERA PHARMACEUTICALS : Announces Proposed Public Offering of Common Stock
03/25 ANTHERA PHARMACEUTICALS : Reports 2014 Fourth Quarter and Fiscal Year Financial ..
03/25 ANTHERA PHARMACEUTICALS : Announces $3 Million Research Award from Cystic Fibros..
03/25 ANTHERA PHARMACEUTICALS : Announces Completion of Interim Analysis from Phase 3 ..
03/23 ANTHERA PHARMACEUTICALS : Announces Completion of Public Offering of Common Stoc..
03/20 ANTHERA PHARMACEUTICALS : Entry into a Material Definitive Agreement, Financial ..
03/20 ANTHERA PHARMACEUTICALS : Posts Proposed Public Offering of Common Stock
More news
Sector news : Biopharmaceuticals
10:42p ASTELLAS PHARMA : Celebrates 10th Anniversary
10:25p Neurocrine,Mitsubishi Tanabe To Develop &Commercialize VMAT2 Inhibitor NBI-98..
07:48p MYLAN NV : N.V. : Announces Pricing of Secondary Public Offering of a Portion of..
More sector news : Biopharmaceuticals
Comments 
Advertisement
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF